Hvað þýðir "Hreinsa"?
Dýrið ber ekki stökkbreytinguna. Það mun ekki þróa sjúkdóminn og mun ekki gefa það áfram.
Autosomal Dominant Progressive Retinal Atrophy (DPRA) is a genetic eye disorder affecting dogs. DPRA leads to progressive vision loss and eventual blindness if left undetected and unmanaged. A DNA test for DPRA helps breeders identify carriers, reducing disease prevalence in future litters. Early genetic testing ensures healthier puppies and protects the breed's overall visual health. DPRA DNA testing is simple, accurate, and essential for responsible dog breeding practices. Regular screening empowers dog owners to make informed breeding decisions and protect canine vision. Invest in DPRA genetic testing today for healthier, happier dogs and enhanced breed integrity.
The autosomal dominant progressive retinal atrophy (dPRA) DNA test identifies a genetic mutation causing vision loss in dogs. dPRA is inherited as an autosomal dominant trait, meaning only one affected copy of the gene is sufficient for disease to manifest. Early genetic testing allows breeders and owners to detect carriers and affected individuals, guiding responsible breeding practices. Regular screening can help reduce the prevalence of dPRA, ensuring healthier generations. Ultimately, DNA testing helps maintain canine eye health and improves overall breed quality.
Þetta DNA próf er innifalið frá pakkanum okkar Basic — og er líka hluti af pökkunum Basic, Standard, Advanced, Complete.
Skoða DNA prófunarpakka →Autosomal Dominant Progressive Retinal Atrophy (dPRA) is a hereditary eye disorder characterized by a gradual degeneration of the retina, leading to progressive vision impairment and eventual blindness in affected dogs. Unlike recessive forms of PRA, this condition is inherited through an autosomal dominant genetic pattern, meaning only one copy of the faulty gene, inherited from either parent, is sufficient to cause the disease.
Dogs affected by dPRA typically exhibit initial symptoms such as night blindness, difficulty navigating in low-light conditions, and increased pupil dilation. Over time, as retinal degeneration progresses, daytime vision also deteriorates, ultimately resulting in complete blindness. The rate of progression and the age at which symptoms first appear can vary significantly among individual dogs.
dPRA follows a dominant inheritance pattern, meaning that a dog with only one affected allele from either parent will exhibit the disease. Consequently, each offspring of an affected dog has a 50% chance of inheriting the disorder. Due to this dominant mode of inheritance, the condition can rapidly spread within a breeding line if not properly monitored and managed.
The DNA test for dPRA identifies the presence or absence of the genetic mutation responsible for the disease. It is a reliable tool allowing breeders and veterinarians to detect affected or carrier animals before clinical signs appear. Early identification is crucial in making informed breeding decisions and helps prevent the propagation of the disorder in future generations.
DNA testing provides vital information to dog owners, breeders, and veterinarians to manage the condition effectively. By identifying affected individuals early, breeding programs can reduce or eliminate the occurrence of dPRA, enhancing breed health and improving the quality of life for dogs. Additionally, early detection allows dog owners to implement appropriate management strategies, such as regular veterinary monitoring, adjustments to home environments, and other supportive care to improve the affected dog's quality of life.
Autosomal Dominant Progressive Retinal Atrophy is a serious genetic condition that significantly impacts canine health and quality of life. DNA testing represents a valuable method for early detection, responsible breeding, and effective disease management. Through careful genetic screening and informed breeding decisions, it is possible to reduce the prevalence and impact of dPRA in canine populations.
Dýrið ber ekki stökkbreytinguna. Það mun ekki þróa sjúkdóminn og mun ekki gefa það áfram.
Nei. Dýrið er almennt heilbrigt en getur sent stökkbreytinguna til þess afkvæmi.
Það ber tvö stökkbreytt eintök. Búist er við klínískum einkennum eftir því sjúkdómnum. Það ætti ekki að rækta það.
Sumir sjúkdómar eru kyntengdir, þannig að tjáning þeirra er mismunandi eftir því kynlíf dýra.
This DNA test detects the mutation associated with Autosomal Dominant Progressive Retinal Atrophy (dPRA) in order to identify clear, carrier, or at-risk animals.
DNA próf hjálpar ræktendum að skipuleggja öruggari pörun og draga úr hættu á að stökkbreytingin berist til afkvæma.
Erfðastillingin sem tilkynnt er um fyrir þetta próf er Autosomal Dominant.
This test analyses the mutation RHO c.11C>G.
Ekki endilega. Túlkun fer eftir erfðamynstri og arfgerðinni sem myndast.
Kijas James W, Cideciyan Artur V, Aleman Tomas S, Pianta Michael J, PearceKelling Susan E, Miller Brian J, Jacobson Samuel G, Aguirre Gustavo D, Acland Gregory M. Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6328-33. doi: 10.1073/pnas.082714499. Epub 2002 Apr 23.
Þitt næði, þitt val
Við notum nauðsynlegar vafrakökur til að keyra vefsíðuna. Valfrjálsar vafrakökur (svo sem innbyggðar efnisveitur) eru sjálfgefnar óvirkar og aðeins virkar ef þú samþykkir. Þú getur breytt vali þínu hvenær sem er með því að nota „Cookies“ hnappinn.
Nauðsynlegt fyrir kjarnaeiginleika og öryggi. Alltaf virkt.
Bætir eiginleika eins og vistun vals eða innfellingar án auglýsinga.
Hjálpar okkur að skilja síðunotkun. Sjálfgefið óvirkt.
Auglýsingar/rakningar á vefsvæðum (sum vídeó/kortum innfelld). Sjálfgefið óvirkt.